Introduction: Yttrium-90 ( 90 Y) microsphere post-treatment imaging reflects the true
Tc-MAA and 90 Y microspheres SPECT/CT. 8, 9 The authors used tumor to normal liver ratio to evaluate the uptake on response and liver toxicity clinical data. 10 The major problem in 90 Y bremsstrahlung imaging is the lack of a pronounced photopeak energy due to the continuous and broad energy spectrum of bremsstrahlung photons giving it a poor image quality. As a result, various studies based on phantom and Monte Carlo (MC) simulation have recommended appropriate energy windows in accordance with the collimator used. [11] [12] [13] [14] It has been shown, often in conjunction with phantom studies that the incorporation of MC simulations to clinical images gives an optimal accuracy of bremsstrahlung images by compensating for photons through correction for attenuation, scatter, and collimator-detector response. [13] [14] [15] Alternately, studies have demonstrated the feasibility of 90 Y PET/CT imaging excelling in contrast and resolution compared to bremsstrahlung SPECT/CT. 16, 17 A recent study by Yue et al. 17 concluded that both modalities are com- where images degraded by the point spread function (PSF) of the detector and additive noises are corrected. 19, 20 The choice of a maximum likelihood algorithm has the benefit of producing good quality images in the presence of high noise levels by preserving positive values through accounting for fluctuation in the signal and thus limiting noise amplification.
A is the reconstructed image degraded by the response of the detector, A' is the contrast recovered image where A 0 0 = A, ⊗ is the 3D (x, y, z) convolution operation and i is the iteration number. In our study the PSF was fixed and the only iterative maximum likelihood estimate was the image. The PSF of the collimator-detector response was modeled by the Gaussian function according to Eq. (2) where σ was found from the relationship with full-width at half-maximum
PSFðx; y; zÞ ¼ 1 SPECT/CT images were evaluated using contrast to noise ratio (CNR) and contrast recovery coefficients (Q H ) 16 for the patient and phantom studies respectively as given by Eqs. (3) and (4). Our analysis of quantitative image improvement is based on matched VOIs between the CT and SPECT images as this is required for dosimetry estimation.
M T is the mean count in tumor VOIs, M B is the mean count in healthy liver VOIs, C S is the mean count in the sphere VOIs, C B is the mean count in the background VOIs and R is the true sphere to background ratio. The block diagram of the employed RL algorithm is shown in Fig. 1 . The iteration number for the algorithm was chosen at the point of maximum likelihood where the contrast recovery coefficient for the 34 mm sphere was at its maximum value, which corresponded to a decline in the associated root mean square error (RMSE) between two consecutive iterative image estimates, which was found to be at the sixth iteration as shown in Fig. 2 . The contrast improvement algorithm using Richardson-Lucy deconvolution is a new idea integrated in this approach.
2.C | SPECT calibration factor measurement
The calibration factor (CF) was defined as the ratio of the total used counts from the liver segments only. In method 2 the liver was first segmented as described in the image processing section and total counts within the liver VOIs were taken. This method avoids counts due to image artifacts. The motivation for using directly the patients' liver uptake to calculate the CF is that due to the proximity of the treatment to the target area where the 90 Y microspheres are deposited predominantly in the liver, the 90 Y activity can be determined with high accuracy. 21 Calibration curves were generated using linear regression analysis to derive the relationship between patient administered activity and reconstructed counts. The CFs were calculated from the slopes of the calibration curves.
For the phantom study, the total reconstructed counts within the phantom boundary were considered. The total activity was the sum of the activities inside the spheres and the background. The CF from the phantom study was evaluated to be within the 95% confidence interval (CI) of the calibration curves from the 90 Y microsphere patient studies to validate its application on the phantom images. 
2.D | Activity estimation and comparison with the administered dose
mutual information is explained by Maes et al. 23 Mean CPU time to register two images was about 15 min on a standard PC.
2.F | Tumor segmentation and tumor to liver ratio calculation (TLR)
Quantitative uptake analysis on 99m
Tc-MAA SPECT/CT for tumor delineation is usually done using an isocontour method with a dedicated software. 8 In our study tumor segmentation based on the uptake of 
2.G | Absorbed dose estimation
The voxel S-value method was used to estimate 3D radiation absorbed dose in
90
Y bremsstrahlung SPECT/CT images. 25, 26 Cubical voxel S values for the pixel size of 4.664 mm were determined using linear interpolation from 3 and 6 mm pixel sizes calculated by Franquiz et al. and Bolch et al. 25, 26 It is expected that errors are associated with using a linear interpolation for estimating S-values for a specific cubic voxel size from tabulated results. 27 
D T is the absorbed dose at the target voxel (mGy), A (MBq) is the cumulated activity from the surrounding source voxels, ⊗ is the 3D convolution and S is the voxel S-value (mGy/MBq) for each associated source distance to the target voxel. Cumulative dose-volume histograms (cDVHs) and isodose curves were generated for the tumor and healthy liver VOIs from the SPECT dose map images.
2.H | Statistical analysis
Quantitative parameters are presented as mean ± SD and ranges.
Linear regressions were generated between administered activities (independent variable) and cps for the purpose of predicting 
3.B | SPECT CF
Results of the regression analyses of the relationships between cps and administered activity gave the following results, the slopes being 
3.C | Activity estimation and comparison with the administered dose
The total activity inside the liver was estimated for each patient using the two CFs. For CF 1, total liver activity estimation resulted in mean percent error of 59 ± 5%. Applying CF 2 gave the smallest error (−5 ± 13%), thus it was used for subsequent analysis. Table 2 shows results of total activity estimation within the liver VOIs using CF 2 . For most of the patients the estimated total liver activity percent errors were within ±10% giving an overall satisfactory results. As our study is retrospective based on anonymized data, we couldn't provide possible clinical reasons for the larger deviations of the estimated activities in some of the patients.
Results of activity estimates inside the spheres and the background for the phantom study gave total mean percent error of Table 3 ).
3.E | Tumor segmentation and TLR comparison
The total mean TLR was 9.4 ± 9.2 and 5.0 ± 2.2 on Y microsphere SPECT/CT, respectively. Figure 7 shows the scatterplot of mean TLRs from the two images displaying a significant correlation (r = 0.9, P = 0.00). From the plot, one patient appears to be an outlier (Grubbs' outlier test, P = 0.00), and taking this patient out of the analysis gave a reduced correlation (r = 0.6, P < 0.05). image of the sphere. 18 In addition, using an activity similar to clinically administered 90 Y microsphere is beneficial in increasing accuracy of the calculation due to an increase in sample size of the counting statistics.
3.F | Absorbed dose estimation
With the clinically available reconstruction method and application of contrast recovery algorithm, total liver activity estimation gave percent error of −5 ± 13 using the CF found from counts within the liver VOIs. Siman et al. 18 generated a global CF derived from patient studies where entire counts within the FOV were considered. The global CF was applied to an IEC phantom with a 37 mm sphere insert and the authors reported an error of −25%
with respect to the true activity. For our phantom study, we used CF estimated from the total reconstructed counts, which was within 95% CI of the patient calibration curve, and obtained total mean From our dosimetry analysis, the administered activity showed a strong correlation with the absorbed dose in the healthy liver, however, the relationship was weak with tumor absorbed dose. There are several factors that could contribute to the correlation between the absorbed doses and the administered activity. The higher non-uniform microsphere distribution within the tumor vasculature compared to the healthy liver could contribute to the more proportional dose deposition in the healthy liver parenchyma vs to the tumor region. Informed consent was waived for all patients included in this retrospective study. 
